Key points
- Even the best treatment works less well if it starts late, is left unfinished or its tablets are missed.
- Delay has a cost: every 4 weeks' delay in starting chemotherapy after bowel cancer surgery was linked to a 14% higher risk of death [2].
- Do not miss tablets: women who stopped their breast cancer hormone tablets early had lower survival [5].
- Fever during chemotherapy is an emergency: every hour's delay in antibiotics raised the risk of death [9].
1. Start treatment on time
After diagnosis there is usually time for tests and planning over a few weeks, but this should not stretch into months:
- Breast cancer surgery: in more than 200,000 patients in the US, each extra month of delay before surgery was linked to about a 10% higher risk of death; the effect was also seen in stages 1 and 2 [1].
- Chemotherapy after bowel cancer surgery: every 4 weeks' delay in starting it was linked to 14% lower survival [2].
If your surgery, radiotherapy or chemotherapy appointment has been pushed back, tell your doctor and ask whether there is a faster way.
2. Finish radiotherapy without breaks
In radiotherapy, gaps between sessions give cancer cells a chance to grow back:
- Cervical cancer: when the whole course took more than 55 days, survival fell by about 0.6% for each extra day [3].
- Head and neck cancers: radiotherapy lasting longer than 56 days was linked to a 25% higher risk of death [4].
Plan your travel for the sessions. If you have a side effect such as mouth sores or diarrhoea, ask the team to treat it so you do not have to pause.
3. Take your tablets every day, to the end of the course
Many of today's treatments are tablets taken at home for months or years. Nobody watches you take them, so they are easy to miss:
- Hormone therapy for breast cancer: 31% of women stopped the tablets early. Their 10-year survival was 74%, compared with 81% in those who continued [5].
- Chronic myeloid leukaemia (imatinib tablets): in patients who took 90% or fewer of their tablets, a deep molecular response occurred in 28%, compared with 95% in regular takers [6].
- Childhood leukaemia: if fewer than 95% of the maintenance tablets were taken, the risk of the disease coming back was about 4 times higher [7] (Can childhood cancer be cured?).
How not to miss your tablets
- 1
Choose a fixed time
Link the tablet to a daily habit, such as breakfast or brushing your teeth at night.
- 2
Set a reminder
A phone alarm, a weekly pill box or a calendar on the fridge helps.
- 3
Get more before you run out
Have the prescription and the medicine ready at least a week early so there is no gap.
- 4
Report side effects, do not stop the medicine
Most side effects can be treated or improve with a dose change; that decision is for your doctor.
4. The full dose and preventing infection
Sometimes a chemotherapy dose is lowered or delayed because white blood cells have dropped. In randomised studies, using a white cell booster (G-CSF, such as filgrastim (Persian)) with chemotherapy slightly lowered deaths from any cause; the greatest benefit was with curative and intensive schedules [8]. Ask your doctor whether you need it.
When should I contact a doctor?
A fever of 38 °C or higher during chemotherapy is an emergency: go to the emergency department at once and say you are having chemotherapy. In one study, each hour's delay in the first antibiotic dose was linked to about an 18% higher risk of death [9]. Also, if your treatment appointment has slipped by more than a few weeks or you cannot take your tablets, contact the care team that week (low blood counts and infection (Persian)).
Read more
Notes for doctors (for physicians)
Show detailsHide
Time to breast surgery. SEER-Medicare (94,544 patients): HR for death 1.09 per 30-day interval and sHR for cancer-specific death 1.26 per 60 days; NCDB (115,790 patients): HR 1.10, significant in stages I and II [1].
Time to adjuvant chemotherapy in colorectal cancer. Meta-analysis of 10 studies (15,410 patients): HR for overall survival 1.14 (1.10 to 1.17) per 4 weeks [2].
Overall treatment time of radiotherapy. Cervix (209 patients): 5-year survival 65% vs 54% for less than 55 days vs 55 days or more; 0.6% loss of survival per extra day [3]. Head and neck (NCDB, 19,531 patients): duration over 56 days HR 1.25 (1.14 to 1.37), HR 1.29 with chemoradiotherapy [4].
Adherence to oral therapy. Adjuvant hormone therapy: early discontinuation HR 1.26 and non-adherence HR 1.49 [5]. Imatinib in CML: adherence ≤90% with 6-year MMR of 28.4% vs 94.5%; with adherence ≤80% no molecular responses were seen [6]. 6-mercaptopurine in childhood ALL: adherence below 95% with relapse HR 4 to 5.7 [7].
Maintaining dose intensity. Meta-analysis of 61 trials: primary G-CSF RR for death 0.93 (0.90 to 0.96), largest effect in dose-dense regimens (RR 0.89) and curative-intent treatment (RR 0.91) [8].
In practice. Record and track the key intervals (diagnosis to surgery, surgery to chemotherapy, overall radiotherapy time); ask about adherence at every visit; have an "antibiotics within 1 hour" pathway for neutropenic fever (10 cheap steps).
Scientific evidence
Show detailsHide
Scientific evidence
2 itemsOutpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia
References
9 referencesShow all referencesClose the reference list
Numbers in the text, such as [1], refer to these sources. Sources with a “Study card” button are summarised in the site’s evidence library.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
This page is based on reputable scientific sources and was last updated on 27 October 2026. The content of this website is for educational and informational purposes only and does not replace consultation, diagnosis or treatment by a specialist physician. Consult your treating physician about any treatment decision.
